Figure 3.
Predictive values of HBeAg seroclearance at month 6 (a) and HBsAg reduction ≥0.5 log10 IU/ml within 6 months (b) of entecavir treatment on HBsAg seroclearance. HBeAg: Hepatitis B e antigen; HBsAg: Hepatitis B surface antigen.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.